CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Dimethyl fumarate

Last Updated: February 4, 2013
Result type: Reports
Project Number: SR0309-000
Product Line: Reimbursement Review

Generic Name: Dimethyl fumarate

Brand Name: Tecfidera

Manufacturer: Biogen Idec Canada Inc.

Therapeutic Area: Multiple sclerosis, relapsing-remitting

Indications: Multiple Sclerosis, relapsing

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: September 25, 2013

Recommendation Type: List with criteria/condition